ASCO GU 2017

2017 Genitourinary Cancers Symposium

February 16-18th 2017

Rosen Shingle Creek

Orlando, FL

Thursday, February 16th , POSTER SESSION A: PROSTATE CANCER

11:30AM-1PM; 5:15PM-6:15PM

 

BOARD E17
Single cell phenogenomic subtyping of circulating tumor cells (CTCs) identify intercellular tumor heterogeneity (het) and multiple resistance mechansisms in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). (Abstract 139)
First Author: Howard Scher

 

BOARD G23
Glucocorticoid receptor (GR) expression in circulating tumor cells (CTCs) to prognosticate overall survival (OS) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with androgen receptor signaling inhibitors (ARSi). (Abstract 194)
First Author: David Wise

 

Friday, February 17th, POSTER SESSION B: PROSTATE CANCER, UROTHELIAL CARCINOMA

12:15PM-1:45PM; 6PM-7PM

 

BOARD B4
Characterization of circulating tumor cells in patients with localized high risk prostate cancer, post-prostatectomy. (Abstract 110)
First Author: Terence Friedlander